CAP-TB News

15 June, 2017
People with low levels of vitamin A who live with individuals who were sick with tuberculosis were 10 times more likely to develop the disease than people with high levels of the nutrient, according to research led by investigators at Harvard Medical School. The findings, published in May in... Read more
15 June, 2017
6 JUNE 2017 | GENEVA - New advice on which antibiotics to use for common infections and which to preserve for the most serious circumstances is among the additions to the WHO Model list of essential medicines for 2017. Other additions include medicines for HIV, hepatitis C, tuberculosis and... Read more
9 June, 2017
Four years ago, Médecins Sans Frontières (MSF) made the decision to sponsor and run its own tuberculosis clinical trial. The aim was to find a new treatment regimen for drug-resistant tuberculosis (TB) that was radically better than what was currently available. Read the full article here: https... Read more
9 June, 2017
Today I announce that Australia, Papua New Guinea, and the World Bank have agreed to a new health security initiative to address multi-drug resistant tuberculosis (MDR-TB). The Australian Government will contribute approximately $20 million in grant funding to the Emergency Tuberculosis Project,... Read more
5 June, 2017
Imperial scientists have found how a common antibiotic could help reduce lung destruction in people with Tuberculosis (TB). TB is a leading cause of mortality worldwide, causing 1.8 million deaths in 2015 and infecting one in three people globally, with or without symptoms. Left untreated, the... Read more
5 June, 2017
Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference. DOT is a... Read more
24 May, 2017
In a study published in the journal ‘Cell Reports’, the research shows that the broad-spectrum effects of the Bacilus Calmette-Guerin (BCG) vaccine could be mediated by metabolic and epigenetic changes in white blood cells called monocytes in a process called ‘trained immunity’. The discovery could... Read more
22 May, 2017
A microchip-based test developed by A*STAR researchers can diagnose tuberculosis in 15 minutes. The test meets the speed, cost, accessibility and disposal standards recommended by the World Health Organization for detecting the deadly disease. Tuberculosis is caused by the bacterium Mycobacterium... Read more
12 May, 2017
HANOVER, NH - Investigators at Dartmouth's Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease. "We are very... Read more
12 May, 2017
Background Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis are emerging worldwide. The Green Light Committee initiative supported programmatic management of drug-resistant tuberculosis in 90 countries. We used estimates from the Preserving Effective TB Treatment Study to... Read more
27 April, 2017
MUMBAI (Reuters) - Japanese drugmaker Otsuka Pharmaceutical aims to apply for approval of its tuberculosis (TB) drug delamanid in India within three months, a senior company official said, as calls grow for expanded access to the life-saving medicine. India accounts for about a quarter of the world... Read more
27 April, 2017
According to the World Health Organization, 10.4 million people fell ill with tuberculosis (TB) and 1.8 million died from it in 2015 alone. People with HIV are 30 times more susceptible to the disease, and over 95% of the deaths occur in low- and middle-income countries. The need for effective and... Read more
24 April, 2017
Sierra Leone is among the 30 countries in the world that carries a severe burden of tuberculosis (TB). Fifteen of the countries with the highest TB infection rates are in Africa, WHO reports. TB is a poverty disease and the poor and vulnerable suffer the most. Adult men and women in their most... Read more
24 April, 2017
WASHINGTON ― When Baltimore resident Arjun kisses his 6-year-old daughter’s forehead, it’s not always just a sign of affection. His daughter, Sujata, is onto him. “Is that a temperature kiss?” she asks. Arjun compulsively checks his little girl’s temperature for a reason. Sujata is the survivor of... Read more
18 April, 2017
NEW DELHI: The Centre has decided to expand the availability of Bedaquiline, a drug used for treatment of drug-resistant tuberculosis, across the country, the Rajya Sabha was informed today.  Union Health Minister J P Nadda, in a written reply, also said that the states are being prepared to... Read more
18 April, 2017
Although tuberculosis (TB) cases and deaths declined significantly between 2011 and 2015, one subpopulation of patients is being hit harder by TB infections more than ever. Individuals living with HIV showed a 40% increase in coinfection with TB over the same study period. In a public statement on... Read more
10 April, 2017
Tuberculosis, once better known as consumption for the way its victims wasted away, has a long and deadly history, with estimates indicating it may have killed more people than any other bacterial pathogen. Consumption played a role in many of our stories of the Old West, but even today — despite $... Read more
10 April, 2017
A new KTP Associate, Joseph Canyelles Pericas (Pep), will be working at the Redcar-based company over the next two years on a disposable TB kit for use in the developing world. The Knowledge Transfer Partnership, run by Innovate UK, the Government’s Innovation Agency, not only provides Epigem with... Read more
5 April, 2017
Scientists from LSTM's Research Centre for Drugs and Diagnostics (RCDD) have described in a paper published today in Scientific Reports, a new way of screening potential treatments for Tuberculosis (TB) which may assist in the identification and prioritisation of new therapies which could... Read more
5 April, 2017
Today, World TB Day, sees the launch of the PLOS Tuberculosis Channel: https://channels.plos.org/tuberculosis Channels are resources for communities: a single destination that features curated content selected from PLOS journals as well as the broader literature, supplemented by commentary, blogs,... Read more

Pages